Tarsus Pharmaceuticals
The Senior Director Regulatory Affairs Strategy at Tarsus Pharmaceuticals will provide regulatory thought leadership and strategic guidance across product development, filing, and lifecycle management to ensure timely approvals and compliant post‑market performance in the US and international markets. The role involves leading cross‑functional teams, influencing regulatory decisions, and managing US regulatory submissions and approvals for assigned projects.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
20% above the average for this role
Associate Director, Regulatory Affairs ROW
Acadia Pharmaceuticals Inc.
Associate Director, Regulatory Affairs US Lead, Regulatory Science & Execution
AstraZeneca
Manager, Regulatory Affairs
Regeneron Pharmaceuticals
Director, Regulatory Affairs, Strategy
LeonaBio
Director, Regulatory Affairs
Cytokinetics
Senior Manager, Regulatory Affairs US & Canada Strategy Lead – Therapeutic Neurotoxins - Hybrid
AbbVie